{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:57:10Z","timestamp":1792277830293,"version":"4.4.0"},"reference-count":205,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1444"],"award-info":[{"award-number":["PSAU\/2023\/R\/1444"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154591","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T02:19:59Z","timestamp":1686277199000},"page":"154591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Angiogenesis and prostate cancer: MicroRNAs comes into view"],"prefix":"10.1016","volume":"248","author":[{"given":"Jitendra","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla A.","family":"Tayyib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduladheem Turki","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif Hameed","family":"Hlail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman S.","family":"Zabibah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulug\u2019bek N.","family":"Vokhidov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alsaikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpamala","family":"Ramaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lathamangeswari","family":"Chinnasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-11-38","article-title":"Functional proteomic analysis of seminal plasma proteins in men with various semen parameters","volume":"11","author":"Sharma","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib2","first-page":"228","article-title":"The risk factors of prostate cancer and its prevention: a literature review","volume":"48","author":"Perdana","year":"2017","journal-title":"Acta Med. Indones."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib4","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.prp.2023.154591_bib5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/cancers11091390","article-title":"Docetaxel combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K\/AKT signaling pathway","volume":"11","author":"Singh","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154591_bib6","series-title":"Seminars in oncology","article-title":"Molecular pathogenesis and progression of prostate cancer","year":"2013"},{"issue":"9","key":"10.1016\/j.prp.2023.154591_bib7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/cancers11091355","article-title":"Current treatment options for metastatic hormone-sensitive prostate cancer","volume":"11","author":"Cattrini","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","article-title":"The contribution of angiogenesis to the process of metastasis","volume":"21","author":"Bielenberg","year":"2015","journal-title":"Cancer J. (Sudbury, Mass)"},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ygyno.2021.03.020","article-title":"Non-coding RNAs related to angiogenesis in gynecological cancer","volume":"161","author":"Rahimian","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2023.154591_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.omto.2021.04.002","article-title":"Angiogenesis-related non-coding RNAs and gastrointestinal cancer","volume":"21","author":"Razavi","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.prp.2023.154591_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.716462","article-title":"Roles of Non-coding RNAs and Angiogenesis in Glioblastoma","volume":"9","author":"Balandeh","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.prp.2023.154591_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153082","article-title":"Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis","volume":"216","author":"Mardani","year":"2020","journal-title":"Pathol., Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib13","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/jcp.26049","article-title":"Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis","volume":"233","author":"Mashreghi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2023.154591_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.biopha.2017.01.161","article-title":"Green tea and its anti-angiogenesis effects","volume":"89","author":"Rashidi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154591_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106913","article-title":"The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer","volume":"88","author":"Sadri Nahand","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.prp.2023.154591_bib16","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1007\/s12035-023-03321-y","article-title":"Non-coding RNAs aNd exosomal non-coding RNAs in traumatic brain injury: the small player with big actions","volume":"60","author":"Mohamadzadeh","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prp.2023.154591_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-023-00623-0","article-title":"Role of non-coding RNAs in neuroblastoma","author":"Anoushirvani","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2023.154591_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1065837","article-title":"Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression","volume":"10","author":"Ahangar Davoodi","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2023.154591_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1014949","article-title":"Exosomal long non-coding RNAs: novel molecules in gastrointestinal cancers' progression and diagnosis","volume":"12","author":"Roshani","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.154591_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-0716-2823-2_2","article-title":"Exosomal MicroRNA Profiling","volume":"2595","author":"Rahimian","year":"2023","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"key":"10.1016\/j.prp.2023.154591_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.omtn.2022.06.017","article-title":"Cytokines and microRNAs in SARS-CoV-2: what do we know? Molecular therapy","volume":"29","author":"Rarani","year":"2022","journal-title":"Nucleic Acids"},{"key":"10.1016\/j.prp.2023.154591_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/5584_2022_715","article-title":"Virus, exosome, and microRNA: new insights into autophagy","volume":"1401","author":"Sadri Nahand","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-018-0766-4","article-title":"New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.prp.2023.154591_bib24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.133.2.275","article-title":"Isolation of a tumor factor responsible for angiogenesis","volume":"133","author":"Folkman","year":"1971","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.prp.2023.154591_bib26","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. life Sci.: CMLS"},{"issue":"114","key":"10.1016\/j.prp.2023.154591_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003149","article-title":"Forty-year journey of angiogenesis translational research","volume":"3","author":"Cao","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"23","key":"10.1016\/j.prp.2023.154591_bib28","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.prp.2023.154591_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10456-019-09684-y","article-title":"Models and molecular mechanisms of blood vessel co-option by cancer cells","volume":"23","author":"Zhang","year":"2020","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.4904","article-title":"Hostile takeover: How tumours hijack pre\u2010existing vascular environments to thrive","volume":"242","author":"Winkler","year":"2017","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.prp.2023.154591_bib31","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.3390\/ijms20112676","article-title":"Targeting angiogenesis in prostate cancer","volume":"20","author":"Melegh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154591_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"cell"},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biomedicines5020034","article-title":"The role of angiogenesis in cancer treatment","volume":"5","author":"Rajabi","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2023.154591_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1016045012466","article-title":"Multiple angiogenesis stimulators in a single malignancy: implications for anti-angiogenic tumour therapy","volume":"4","author":"Pavlakovic","year":"2001","journal-title":"Angiogenesis"},{"issue":"19","key":"10.1016\/j.prp.2023.154591_bib35","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1345\/aph.1L426","article-title":"Intricacies of bevacizumab-induced toxicities and their management","volume":"43","author":"Gressett","year":"2009","journal-title":"Ann. Pharmacother."},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib37","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib38","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/bjc.1996.456","article-title":"Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells","volume":"74","author":"Harper","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib39","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0022-5347(01)64775-X","article-title":"Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells","volume":"157","author":"Ferrer","year":"1997","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib40","first-page":"2533","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study","volume":"61","author":"Bok","year":"2001","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154591_bib41","first-page":"1932","article-title":"Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480","volume":"7","author":"George","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0090-4295(99)00167-3","article-title":"Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer","volume":"54","author":"Duque","year":"1999","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0090-4295(99)00202-2","article-title":"Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma","volume":"54","author":"Gettman","year":"1999","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib44","first-page":"401","article-title":"Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma","volume":"143","author":"Weidner","year":"1993","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib45","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1158\/0008-5472.CAN-06-3637","article-title":"Ponnazhagan S. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model","volume":"67","author":"Isayeva","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154591_bib46","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12094-015-1480-y","article-title":"Role of taxanes in advanced prostate cancer","volume":"18","author":"Cassinello","year":"2016","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41556-020-00616-3","article-title":"Prostate cancer hijacks the microenvironment","volume":"23","author":"Thienger","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.prp.2023.154591_bib48","series-title":"Seminars in oncology","article-title":"Docetaxel (Taxotere) in hormone-refractory prostate cancer","year":"2000"},{"key":"10.1016\/j.prp.2023.154591_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4939-7845-8_9","article-title":"Protocols for the study of taxanes chemosensitivity in prostate cancer","author":"Luz Flores","year":"2018","journal-title":"Prostate Cancer.: Methods Protoc."},{"key":"10.1016\/j.prp.2023.154591_bib50","series-title":"Seminars in oncology","article-title":"Mechanisms of action of taxanes in prostate cancer","year":"1999"},{"key":"10.1016\/j.prp.2023.154591_bib51","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2165\/00003495-200161150-00003","article-title":"Treatment options in hormone-refractory prostate cancer: current and future approaches","volume":"61","author":"Harris","year":"2001","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.prp.2023.154591_bib52","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1200\/JCO.1996.14.5.1617","article-title":"Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer","volume":"14","author":"Small","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2023.154591_bib53","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1470-2045(13)70184-0","article-title":"Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial","volume":"14","author":"Tannock","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10637-018-0687-5","article-title":"Phase I\/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer","volume":"37","author":"Barata","year":"2019","journal-title":"Investig. N. Drugs"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/pcan.2015.59","article-title":"A phase 2 multimodality trial of docetaxel\/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy","volume":"19","author":"Armstrong","year":"2016","journal-title":"Prostate Cancer prostatic Dis."},{"key":"10.1016\/j.prp.2023.154591_bib56","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.5039","article-title":"A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC)","author":"Spreafico","year":"2013","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib57","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1261\/rna.7135204","article-title":"Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs","volume":"10","author":"Cai","year":"2004","journal-title":"Rna"},{"issue":"8","key":"10.1016\/j.prp.2023.154591_bib58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7149","key":"10.1016\/j.prp.2023.154591_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.molcel.2014.11.030","article-title":"Dicer-TRBP complex formation ensures accurate mammalian microRNA biogenesis","volume":"57","author":"Wilson","year":"2015","journal-title":"Mol. Cell"},{"issue":"5858","key":"10.1016\/j.prp.2023.154591_bib61","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1126\/science.1149460","article-title":"Switching from repression to activation: microRNAs can up-regulate translation","volume":"318","author":"Vasudevan","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.prp.2023.154591_bib62","first-page":"337","article-title":"Dynamic miRNA\u2013mRNA paradigMs: new faces of miRNAs","volume":"4","author":"Ni","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.prp.2023.154591_bib63","series-title":"Exosomes and MicroRNAs in Biomedical Science","first-page":"1","article-title":"MicroRNA biogenesis and function","author":"Mirzaei","year":"2022"},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib64","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/ijc.25014","article-title":"miRNA control of tumor cell invasion and metastasis","volume":"126","author":"Baranwal","year":"2010","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-022-00317-9","article-title":"MicroRNA let-7 and viral infections: focus on mechanisms of action","volume":"27","author":"Letafati","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.prp.2023.154591_bib66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.omtn.2021.03.011","article-title":"Cell death pathways and viruses: role of microRNAs","volume":"24","author":"Nahand","year":"2021","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.prp.2023.154591_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104692","article-title":"The role of HPV gene expression and selected cellular MiRNAs in lung cancer development","volume":"150","author":"Hussen","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.prp.2023.154591_bib68","first-page":"97","article-title":"Virus, Exosome, and MicroRNA: New Insights into Autophagy. Cell Biology and Translational Medicine","volume":"Volume 17","author":"Sadri Nahand","year":"2022"},{"issue":"10","key":"10.1016\/j.prp.2023.154591_bib69","doi-asserted-by":"crossref","first-page":"17064","DOI":"10.1002\/jcp.28457","article-title":"microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer","volume":"234","author":"Nahand","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ijc.32688","article-title":"Pathogenic role of exosomes and microRNAs in HPV\u2010mediated inflammation and cervical cancer: a review","volume":"146","author":"Sadri Nahand","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"18","key":"10.1016\/j.prp.2023.154591_bib71","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2217\/epi-2020-0026","article-title":"Exosomal microRNAs: novel players in cervical cancer","volume":"12","author":"Nahand","year":"2020","journal-title":"Epigenomics"},{"issue":"8","key":"10.1016\/j.prp.2023.154591_bib72","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1002\/jcp.27956","article-title":"microRNAs: Key Players in virus\u2010associated hepatocellular carcinoma","volume":"234","author":"Sadri Nahand","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/iub.2222","article-title":"The role of miR\u2010146a in viral infection","volume":"72","author":"Nahand","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.prp.2023.154591_bib74","series-title":"Biomedical Science","first-page":"11","article-title":"MicroRNAs in Cancer. Exosomes and MicroRNAs in","author":"Mirzaei","year":"2022"},{"key":"10.1016\/j.prp.2023.154591_bib75","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.biopha.2018.12.022","article-title":"Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases","volume":"110","author":"Fallah","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154591_bib76","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s10637-015-0283-x","article-title":"Long term exposure to antiangiogenic therapy, bevacizumab, induces osteonecrosis","volume":"33","author":"Tabouret","year":"2015","journal-title":"Investig. N. Drugs"},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib77","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/ERC-15-0277","article-title":"mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity","volume":"22","author":"Finetti","year":"2015","journal-title":"Endocr. -Relat. Cancer"},{"issue":"16","key":"10.1016\/j.prp.2023.154591_bib78","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1158\/1078-0432.CCR-10-0156","article-title":"Inhibition of hypoxia inducible factor-1\u03b1 by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E Synthase-1\/vascular endothelial growth factor expression and reduces tumor angiogenesisDPE inhibits tumor angiogenesis","volume":"16","author":"Terzuoli","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.prp.2023.154591_bib79","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1158\/0008-5472.CAN-07-6689","article-title":"Prostaglandin E2 regulates tumor angiogenesis in prostate cancer","volume":"68","author":"Jain","year":"2008","journal-title":"Cancer Res."},{"issue":"28","key":"10.1016\/j.prp.2023.154591_bib80","doi-asserted-by":"crossref","first-page":"44350","DOI":"10.18632\/oncotarget.10051","article-title":"Linking microsomal prostaglandin E Synthase-1\/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer","volume":"7","author":"Terzuoli","year":"2016","journal-title":"Oncotarget"},{"issue":"30","key":"10.1016\/j.prp.2023.154591_bib81","doi-asserted-by":"crossref","first-page":"47444","DOI":"10.18632\/oncotarget.10165","article-title":"MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K\/AKT pathway activity","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib82","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1021\/acs.molpharmaceut.8b01074","article-title":"Codelivery of miR-4638\u20135p and docetaxel based on redox-sensitive polypeptide micelles as an improved strategy for the treatment of castration-resistant prostate cancer","volume":"16","author":"Jiang","year":"2018","journal-title":"Mol. Pharm."},{"issue":"21","key":"10.1016\/j.prp.2023.154591_bib83","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1158\/1078-0432.CCR-15-0217","article-title":"miR-195 inhibits tumor progression by targeting rPS6KB1 in human prostate cancertumor suppressive role of miR-195 in prostate cancer","volume":"21","author":"Cai","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib84","first-page":"1658","article-title":"miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression","volume":"39","author":"Cai","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib85","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3892\/etm.2021.11021","article-title":"miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K\/Akt pathways","volume":"23","author":"Jia","year":"2022","journal-title":"Exp. Ther. Med"},{"issue":"11","key":"10.1016\/j.prp.2023.154591_bib86","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/mc.22204","article-title":"MiR\u2010130b suppresses prostate cancer metastasis through down\u2010regulation of MMP2","volume":"54","author":"Chen","year":"2015","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.prp.2023.154591_bib87","first-page":"6361","article-title":"miR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.prp.2023.154591_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/497d9208-190a-44b7-ac27-aea12183f47c","article-title":"MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3","volume":"8","author":"Zhao","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2023.154591_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-013-0484-0","article-title":"miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer","volume":"30","author":"Li","year":"2013","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib90","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41389-022-00422-6","article-title":"Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer","volume":"11","author":"Ahn","year":"2022","journal-title":"Oncogenesis"},{"issue":"8","key":"10.1016\/j.prp.2023.154591_bib91","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1007\/s13277-016-4919-z","article-title":"MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN\/p-AKT\/HIF-1\u03b1 signaling","volume":"37","author":"Chang","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2023.154591_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1031-5","article-title":"MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells","volume":"15","author":"Yu","year":"2015","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.prp.2023.154591_bib93","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1593\/neo.13998","article-title":"MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer","volume":"15","author":"Colangelo","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.prp.2023.154591_bib94","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12094-019-02217-5","article-title":"MiR-130b\/TNF-\u03b1\/NF-\u03baB\/VEGFA loop inhibits prostate cancer angiogenesis","volume":"22","author":"Mu","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib95","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yexcr.2018.02.028","article-title":"EYA1 promotes tumor angiogenesis by activating the PI3K pathway in colorectal cancer","volume":"367","author":"Cai","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2023.154591_bib97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mce.2019.01.005","article-title":"PTHrP treatment of colon cancer cells promotes tumor associated-angiogenesis by the effect of VEGF","volume":"483","author":"Calvo","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.prp.2023.154591_bib98","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00018-018-2941-6","article-title":"Reciprocal regulations between miRNAs and HIF-1\u03b1 in human cancers","volume":"76","author":"Yang","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"48","key":"10.1016\/j.prp.2023.154591_bib99","doi-asserted-by":"crossref","first-page":"83523","DOI":"10.18632\/oncotarget.18315","article-title":"Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1\u03b1","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7150\/jca.9591","article-title":"Upregulation of miRNA3195 and miRNA374b mediates the anti-angiogenic properties of melatonin in hypoxic PC-3 prostate cancer cells","volume":"6","author":"Sohn","year":"2015","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3217","article-title":"Lack of transforming growth factor-\u03b2 signaling promotes collective cancer cell invasion through tumor-stromal crosstalk","volume":"14","author":"Matise","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2023.154591_bib102","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2217\/fon.09.90","article-title":"Mechanisms of the epithelial\u2013mesenchymal transition by TGF-\u03b2","volume":"5","author":"Wendt","year":"2009","journal-title":"Future Oncol."},{"issue":"11","key":"10.1016\/j.prp.2023.154591_bib103","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.2001.19.11.2856","article-title":"Preoperative plasma levels of transforming growth factor beta1 (TGF-\u03b21) strongly predict progression in patients undergoing radical prostatectomy","volume":"19","author":"Shariat","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2023.154591_bib104","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mc.22005","article-title":"Apigenin inhibits TGF\u2010\u03b2\u2010induced VEGF expression in human prostate carcinoma cells via a Smad2\/3\u2013and Src\u2010dependent mechanism","volume":"53","author":"Mirzoeva","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"7","key":"10.1016\/j.prp.2023.154591_bib105","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","article-title":"Balancing the activation state of the endothelium via two distinct TGF-\u03b2 type I receptors","volume":"21","author":"Goumans","year":"2002","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib106","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/cas.12548","article-title":"Inhibition of transforming growth factor beta\/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer","volume":"105","author":"Ji","year":"2014","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib107","first-page":"503","article-title":"Nodal signaling activates the Smad2\/3 pathway to regulate stem cell-like properties in breast cancer cells","volume":"7","author":"Gong","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2023.154591_bib108","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10555-016-9605-5","article-title":"Plasticity underlies tumor progression: role of Nodal signaling","volume":"35","author":"Bodenstine","year":"2016","journal-title":"Cancer Metastas Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.154591_bib109","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/pros.21326","article-title":"Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration","volume":"71","author":"Vo","year":"2011","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.prp.2023.154591_bib110","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/onc.2012.85","article-title":"CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer","volume":"32","author":"Liu","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-020-00617-2","article-title":"miR-185 inhibits prostate cancer angiogenesis induced by the nodal\/ALK4 pathway","volume":"20","author":"Li","year":"2020","journal-title":"BMC Urol."},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib112","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","article-title":"Growing roles for the mTOR pathway","volume":"17","author":"Sarbassov","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059083","article-title":"Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K\/Akt\/mTOR and MAPK\/ERK signaling in ovarian cancer cells","volume":"8","author":"Lau","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0794-0","article-title":"The role of RICTOR downstream of receptor tyrosine kinase in cancers","volume":"17","author":"Jebali","year":"2018","journal-title":"Mol. Cancer"},{"issue":"14","key":"10.1016\/j.prp.2023.154591_bib115","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"issue":"5712","key":"10.1016\/j.prp.2023.154591_bib116","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"issue":"269","key":"10.1016\/j.prp.2023.154591_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"5","key":"10.1016\/j.prp.2023.154591_bib118","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib119","first-page":"1207","article-title":"MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901","volume":"39","author":"Fan","year":"2018","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib120","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.21873\/anticanres.15436","article-title":"miR-3188 enhances sensitivity of breast cancer cells to ionizing radiation by down-regulating rictor","volume":"41","author":"Hong","year":"2021","journal-title":"Anticancer Res."},{"issue":"17","key":"10.1016\/j.prp.2023.154591_bib121","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1158\/0008-5472.CAN-11-0368","article-title":"The tumor suppressive MicroRNA miR-218 targets the mTOR component rictor and inhibits AKT phosphorylation in oral cancermiR-218 targeting rictor","volume":"71","author":"Uesugi","year":"2011","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154591_bib122","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.18632\/oncotarget.14131","article-title":"Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer","volume":"8","author":"Guan","year":"2017","journal-title":"Oncotarget"},{"issue":"7347","key":"10.1016\/j.prp.2023.154591_bib123","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib124","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006593","article-title":"The VEGF pathway in cancer and disease: responses, resistance, and the path forward","volume":"2","author":"Kieran","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"issue":"7","key":"10.1016\/j.prp.2023.154591_bib126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0968-0004(97)01061-X","article-title":"Phosphoinositide 3-kinases: a conserved family of signal transducers","volume":"22","author":"Vanhaesebroeck","year":"1997","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.prp.2023.154591_bib127","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/141236","article-title":"The Role of PTEN in tumor angiogenesis","volume":"2012","author":"Rodriguez","year":"2012","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ddr.21257","article-title":"The role of miR\u201021 in cancer","volume":"76","author":"Pfeffer","year":"2015","journal-title":"Drug Dev. Res."},{"issue":"11\u201312","key":"10.1016\/j.prp.2023.154591_bib130","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","article-title":"MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)","volume":"411","author":"Zhang","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib131","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1159\/000481648","article-title":"MicroRNA-21 (Mir-21) promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer","volume":"43","author":"Wu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2023.154591_bib132","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tox.2013.02.014","article-title":"miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN","volume":"306","author":"Yang","year":"2013","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib133","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3892\/ijo.2012.1707","article-title":"MiR-21 regulates biological behavior through the PTEN\/PI-3 K\/Akt signaling pathway in human colorectal cancer cells","volume":"42","author":"Xiong","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019139","article-title":"MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1\u03b1 expression","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrc2540","article-title":"The impact of O2 availability on human cancer","volume":"8","author":"Bertout","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib136","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"37","key":"10.1016\/j.prp.2023.154591_bib137","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/sj.onc.1206703","article-title":"Investigating hypoxic tumor physiology through gene expression patterns","volume":"22","author":"Denko","year":"2003","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.prp.2023.154591_bib138","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1097-0142(20001101)89:9<2018::AID-CNCR19>3.0.CO;2-Y","article-title":"Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO2 study","volume":"89","author":"Movsas","year":"2000","journal-title":"Cancer: Interdiscip. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.prp.2023.154591_bib139","article-title":"Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues","author":"Pallares","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.prp.2023.154591_bib140","series-title":"Seminars in urologic oncology","article-title":"Microvessel density in prostate cancer: prognostic and therapeutic utility","year":"1998"},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib141","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ctrv.2008.01.006","article-title":"Hypoxia in prostate cancer: a powerful shield against tumour destruction?","volume":"34","author":"Marignol","year":"2008","journal-title":"Cancer Treat. Rev."},{"issue":"407","key":"10.1016\/j.prp.2023.154591_bib142","doi-asserted-by":"crossref","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","article-title":"Hypoxia-inducible factor 1 (HIF-1) pathway","volume":"2007","author":"Semenza","year":"2007","journal-title":"Sci. 'S. STKE: Signal Transduct. Knowl. Environ."},{"issue":"10","key":"10.1016\/j.prp.2023.154591_bib143","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"22","key":"10.1016\/j.prp.2023.154591_bib144","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cam4.189","article-title":"The effects of nonspecific HIF1\u03b1 inhibitors on development of castrate resistance and metastases in prostate cancer","volume":"3","author":"Ranasinghe","year":"2014","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib146","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cdp.2003.12.009","article-title":"Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis","volume":"28","author":"Zhong","year":"2004","journal-title":"Cancer Detect. Prev."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib147","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1038\/srep12495","article-title":"Hypoxia-inducible miR-182 enhances HIF1\u03b1 signaling via targeting PHD2 and FIH1 in prostate cancer","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib148","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/jcm8122030","article-title":"Insights into the regulation of tumor angiogenesis by micro-RNAs","volume":"8","author":"Leone","year":"2019","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib149","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.2012.48.5268","article-title":"Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer","volume":"32","author":"Michaelson","year":"2014","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154591_bib150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2015.04.002","article-title":"MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastoma","volume":"207","author":"Costa","year":"2015","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.prp.2023.154591_bib151","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/mt.2015.129","article-title":"miR-221\/222 are involved in response to sunitinib treatment in metastatic renal cell carcinoma","volume":"23","author":"Khella","year":"2015","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.prp.2023.154591_bib152","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21873\/cgp.20140","article-title":"Mir-376b-3p is associated with long-term response to sunitinib in metastatic renal cell carcinoma patients","volume":"16","author":"Kovacova","year":"2019","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.prp.2023.154591_bib153","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/jcm9030670","article-title":"miR-221-3p regulates VEGFR2 expression in high-risk prostate cancer and represents an escape mechanism from sunitinib in vitro","volume":"9","author":"Krebs","year":"2020","journal-title":"J. Clin. Med"},{"issue":"46","key":"10.1016\/j.prp.2023.154591_bib154","doi-asserted-by":"crossref","first-page":"81572","DOI":"10.18632\/oncotarget.19197","article-title":"The role of miRNA and lncRNA in gastric cancer","volume":"8","author":"Hao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154591_bib155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.omtn.2019.11.021","article-title":"lncRNA UCA1 functions as a ceRNA to promote prostate cancer progression via sponging miR143","volume":"19","author":"Yu","year":"2020","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib156","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1002\/jcp.29285","article-title":"SP1\u2013mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR\u2010377 to facilitate prostate cancer progression through regulation of ZIC5","volume":"235","author":"Wang","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2023.154591_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154030","article-title":"Research progress on the circRNA\/lncRNA\u2013miRNA\u2013mRNA axis in gastric cancer","author":"Zeng","year":"2022","journal-title":"Pathol. -Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib158","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","journal-title":"RNA Biol."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030733","article-title":"Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types","volume":"7","author":"Salzman","year":"2012","journal-title":"PloS One"},{"issue":"7441","key":"10.1016\/j.prp.2023.154591_bib160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"issue":"7441","key":"10.1016\/j.prp.2023.154591_bib161","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib162","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12257-021-0229-4","article-title":"Hsa_circ_0001165 regulates the malignant phenotype and angiogenesis of prostate cancer cells through miR-654-3p\/DDAH1","volume":"28","author":"Ji","year":"2023","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.prp.2023.154591_bib163","first-page":"1","article-title":"Circ_0005276 promotes prostate cancer progression through the crosstalk of miR-128-3p\/DEPDC1B axis","author":"Li","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.prp.2023.154591_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154317","article-title":"Circ_0057558 accelerates the development of prostate cancer through miR-1238-3p\/SEPT2 axis","volume":"243","author":"Yin","year":"2023","journal-title":"Pathol., Res. Pract."},{"key":"10.1016\/j.prp.2023.154591_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.598817","article-title":"Long non-coding RNAs: the regulatory mechanisms, research strategies, and future directions in cancers","volume":"10","author":"Gao","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.154591_bib166","first-page":"26","article-title":"The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease","author":"Abbasi-Kolli","year":"2022","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.prp.2023.154591_bib167","first-page":"13","article-title":"LncRNAs and the angiogenic switch in cancer: clinical significance and therapeutic opportunities","author":"Mabeta","year":"2022","journal-title":"Genes"},{"issue":"3\u20134","key":"10.1016\/j.prp.2023.154591_bib168","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41434-019-0108-1","article-title":"Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1","volume":"27","author":"Jiang","year":"2020","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01484-5","article-title":"Long noncoding RNA LINC00261 suppresses prostate cancer tumorigenesis through upregulation of GATA6-mediated DKK3","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"15","key":"10.1016\/j.prp.2023.154591_bib170","doi-asserted-by":"crossref","first-page":"12212","DOI":"10.18632\/oncotarget.24198","article-title":"The PCAT3\/PCAT9-miR-203-SNAI2 axis functions as a key mediator for prostate tumor growth and progression","volume":"9","author":"Tao","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib171","first-page":"657","article-title":"AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review)","volume":"43","author":"Salinas-Vera","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib172","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00063030-200923010-00002","article-title":"MicroRNA-based therapeutics for cancer","volume":"23","author":"Wang","year":"2009","journal-title":"BioDrugs: Clin. Immunother., Biopharm. Gene Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib173","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2016.3503","article-title":"Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: \u03bdew trends in the development of miRNA therapeutic strategies in oncology (Review)","volume":"49","author":"Gambari","year":"2016","journal-title":"Int J. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib174","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154591_bib175","doi-asserted-by":"crossref","first-page":"34504","DOI":"10.1038\/srep34504","article-title":"Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer","volume":"6","author":"Flores-P\u00e9rez","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2023.154591_bib176","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1089\/ars.2013.5184","article-title":"Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis","volume":"19","author":"Skrzypek","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.prp.2023.154591_bib177","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"issue":"17","key":"10.1016\/j.prp.2023.154591_bib178","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc.14.116","article-title":"miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents","volume":"6","author":"Baumann","year":"2014","journal-title":"Future Med. Chem."},{"issue":"14","key":"10.1016\/j.prp.2023.154591_bib179","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in Cancer","volume":"16","author":"He","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154591_bib180","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.81847","article-title":"MiRNA-based therapeutics in oncology, realities, and challenges","author":"Balacescu","year":"2019","journal-title":"Antisense Ther."},{"key":"10.1016\/j.prp.2023.154591_bib181","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canep.2018.12.008","article-title":"Liquid biopsy: miRNA as a potential biomarker in oral cancer","volume":"58","author":"Mazumder","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.prp.2023.154591_bib182","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4939-6588-5_9","article-title":"Exosomes-based gene therapy for microRNA delivery","author":"Mathiyalagan","year":"2017","journal-title":"Card. Gene Ther.: Methods Protoc."},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib183","first-page":"215","article-title":"Exosome can prevent RNase from degrading microRNA in feces","volume":"2","author":"Koga","year":"2011","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.prp.2023.154591_bib184","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fgene.2013.00036","article-title":"Exosomal miRNAs as biomarkers for prostate cancer","volume":"4","author":"Hessvik","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2023.154591_bib185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12094-016-1599-5","article-title":"Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer","volume":"19","author":"Valentino","year":"2017","journal-title":"Clin. Transl. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154591_bib186","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pros.23295","article-title":"Exosomal and non\u2010exosomal urinary miRNAs in prostate cancer detection and prognosis","volume":"77","author":"Foj","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.prp.2023.154591_bib187","first-page":"13","article-title":"Exosomal MicroRNA Profiling","author":"Rahimian","year":"2022","journal-title":"Micro Profil.: Methods Protoc."},{"issue":"2","key":"10.1016\/j.prp.2023.154591_bib188","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3892\/ijo.2017.4038","article-title":"Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis","volume":"51","author":"Chen","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"63","key":"10.1016\/j.prp.2023.154591_bib189","doi-asserted-by":"crossref","first-page":"107157","DOI":"10.18632\/oncotarget.22362","article-title":"Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer","volume":"8","author":"Niu","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.prp.2023.154591_bib190","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/pros.22466","article-title":"MiR\u2010146a suppresses tumor growth and progression by targeting EGFR pathway and in ap\u2010ERK\u2010dependent manner in castration\u2010resistant prostate cancer","volume":"72","author":"Xu","year":"2012","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.prp.2023.154591_bib191","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/cas.12548","article-title":"Inhibition of transforming growth factor beta\/SMAD signal by MiR\u2010155 is involved in arsenic trioxide\u2010induced anti\u2010angiogenesis in prostate cancer","volume":"105","author":"Ji","year":"2014","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib192","first-page":"1658","article-title":"miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression","volume":"39","author":"Cai","year":"2018","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib193","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/iub.1720","article-title":"The mi R\u2010203\/SNAI 2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK\u20103\u03b2\/\u03b2\u2010CATENIN signal pathway","volume":"70","author":"Tian","year":"2018","journal-title":"IUBMB Life"},{"issue":"33","key":"10.1016\/j.prp.2023.154591_bib194","doi-asserted-by":"crossref","first-page":"34446","DOI":"10.18632\/oncotarget.5920","article-title":"MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence","volume":"6","author":"Ramalinga","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154591_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-0977-9","article-title":"Inactivation of the Wnt\/\u03b2-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial\u2013mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2","volume":"19","author":"Jiang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2023.154591_bib196","article-title":"MicroRNA-32 suppression: its effects on prostate cancer cells\u2019 capability to proliferate and migrate","author":"Al-Marzook","year":"2023","journal-title":"Drug Res."},{"key":"10.1016\/j.prp.2023.154591_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07472-2","article-title":"miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1","volume":"20","author":"Meng","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154591_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02233-w","article-title":"MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer","volume":"41","author":"Ferri","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154591_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019139","article-title":"MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1\u03b1 expression","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154591_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0615-x","article-title":"MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1\/c-JUN\/VEGFA pathway and predicts aggressive outcome in prostate cancer","volume":"16","author":"Lin","year":"2017","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib201","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/jcm9030670","article-title":"miR-221-3p regulates VEGFR2 expression in high-risk prostate cancer and represents an escape mechanism from sunitinib in vitro","volume":"9","author":"Krebs","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2023.154591_bib202","first-page":"1","article-title":"Hsa_circ_0001165 regulates the malignant phenotype and angiogenesis of prostate cancer cells through miR-654-3p\/DDAH1","author":"Ji","year":"2023","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.prp.2023.154591_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154317","article-title":"Circ_0057558 accelerates the development of prostate cancer through miR-1238-3p\/SEPT2 axis","author":"Yin","year":"2023","journal-title":"Pathol. -Res. Pract."},{"issue":"3","key":"10.1016\/j.prp.2023.154591_bib204","doi-asserted-by":"crossref","DOI":"10.1111\/and.14343","article-title":"Circular RNA circ_0062019 exerts oncogenic properties in prostate cancer via mediating miR\u20101253\/NRBP1 axis","volume":"54","author":"Ren","year":"2022","journal-title":"Andrologia"},{"key":"10.1016\/j.prp.2023.154591_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.624764","article-title":"Circular RNA CircNOLC1, upregulated by NF-KappaB, promotes the progression of prostate cancer via miR-647\/PAQR4 axis","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:58:48Z","timestamp":1774411128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823002911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":205,"alternative-id":["S0344033823002911"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154591","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenesis and prostate cancer: MicroRNAs comes into view","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154591"}}